LON:DOCS Dr. Martens (DOCS) Share Price, News & Analysis GBX 53.48 -0.12 (-0.22%) As of 03:12 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Dr. Martens Stock (LON:DOCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Dr. Martens alerts:Sign Up Key Stats Today's Range 52▼ 54.4050-Day Range 47.98▼ 68.5052-Week Range 43.02▼ 93.25Volume165,430 shsAverage Volume2.52 million shsMarket Capitalization£519.16 millionP/E Ratio7.58Dividend Yield5.61%Price TargetN/AConsensus RatingN/A Company OverviewDr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index. Dr. Martens operates across three geographic regions: EMEA, Americas and APAC. Our product segments include Originals, Fusion, Kids and Casual and a complementary range of Accessories.Read More… Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock News HeadlinesInsider Buying: Dr. Martens plc (LON:DOCS) Insider Buys 297 Shares of StockApril 15, 2025 | insidertrades.comBestselling Dr. Martens sandals that are 'so comfy from day one' are slashed by £42April 26 at 2:35 PM | mirror.co.ukTrump’s Secret Social Security Plan?In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.April 28, 2025 | Paradigm Press (Ad)‘Cute and feminine without being too sweet:’ this Doc Martens shoe is on sale right now, but selling out fastApril 18, 2025 | msn.comDr. Martens is slashing prices on its famous boots and shoes with unheard of discounts up to $100 offApril 18, 2025 | nj.comDr. Martens dropped a limited-edition Bratz Collection of shoes in a nostalgic flashback with ‘bratitude’April 10, 2025 | nj.comDr. Martens x Palace Skateboards Drop Three Takes on DM’s Classic 1461 SilhouetteApril 9, 2025 | msn.comDoc Martens are just $99: Make sure you snag a pair before they’re gone!April 7, 2025 | msn.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Dr. Martens' stock was trading at GBX 72.20 at the beginning of the year. Since then, DOCS stock has decreased by 25.8% and is now trading at GBX 53.60. View the best growth stocks for 2025 here. How were Dr. Martens' earnings last quarter? Dr. Martens plc (LON:DOCS) issued its earnings results on Thursday, November, 28th. The company reported ($1.30) EPS for the quarter. Dr. Martens had a net margin of 7.89% and a trailing twelve-month return on equity of 18.91%. Read the conference call transcript. How do I buy shares of Dr. Martens? Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Dr. Martens own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Martens investors own include boohoo group (BOO), Aston Martin Lagonda Global (AML), ASOS (ASC), Vodafone Group Public (VOD), JD Sports Fashion (JD), Legal & General Group (LGEN) and Lloyds Banking Group (LLOY). Company Calendar Last Earnings11/28/2024Record date for 4/8 Dividend3/06/2025Ex-Dividend for 4/8 Dividend3/06/2025Dividend Payable4/08/2025Today4/27/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Footwear & Accessories Sub-IndustryComputer Software Current SymbolLON:DOCS CIKN/A Webwww.drmartensplc.com Phone44 12 1415 7047FaxN/AEmployees890Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 7.05 Trailing P/E Ratio7.60 Forward P/E Ratio20.77 P/E Growth6.4Net Income£68.97 million Net Margins7.89% Pretax MarginN/A Return on Equity18.91% Return on Assets8.12% Debt Debt-to-Equity Ratio127.27 Current Ratio2.85 Quick Ratio1.13 Sales & Book Value Annual Sales£874.20 million Price / Sales0.60 Cash FlowGBX 3.75 per share Price / Cash Flow14.29 Book ValueGBX 37.80 per share Price / Book1.42Miscellaneous Outstanding Shares970,763,405Free FloatN/AMarket Cap£520.33 million OptionableNot Optionable Beta0.11 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (LON:DOCS) was last updated on 4/28/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Martens With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.